PopelkaSRMillerDMHolenJTKelsoDM. Fluorescence polarisation immunoassay II. Analyser for rapid, precise measurement of fluorescence polarisation with use of disposable cuvettes. Clin Chem1981; 27: 1198–201.
2.
JolleyMEStroupeSDSchwenzerKSFluorescence polarisation immunoassay III. An automated system for therapeutic drug determination. Clin Chem1981; 27: 1575–9.
3.
KroonBBR. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. Eur J Surg Oncol1988; 14: 101–10.
4.
FloraKPSmithSLCraddockJC, Application of a simple HPLC method for the determination of melphalan in the presence of hydrolysis products. J Chromatogr1979; 177: 91–7.
5.
DickJBCBartlettWAIbrahimUColeiroJA. Interference of fluorescein with creatinine assays. In: MartinSMHalloranSP, eds. Proceedings of the ACB National Meeting. London: Association of Clinical Biochemists, 1990: 72.
6.
McClellanSLPerryBWDoumasBT. Effect of fluorescein on clinical laboratory tests. Clin Chem1982; 28: 2335–6.
7.
RenoeBWSanbornJHeroldDA. Fluorescein effect on magnesium and total protein determinations. Clin Chem1982; 28: 1405.
8.
InloesRClarkDDrobniesA. Interference of fluorescein, used in retinal angiography, with certain clinical laboratory tests. Clin Chem1987; 33: 2126–7.
9.
ZeimerRCBlairNPCunha-VazJG. Pharmacokinetic interpretation of vitreous fluorophotometry. Invest Ophthalmol Vis Sci1983; 24: 1374–81.
